{"id":"W2118214176","doi":"10.1186/s12931-015-0249-8","title":"Dose-finding evaluation of once-daily treatment with olodaterol, a novel long-acting β2-agonist, in patients with asthma: results of a parallel-group study and a crossover study","year":2015,"lang":"en","type":"article","venue":"Respiratory Research","topic":"Pharmacological Effects and Assays","field":"Agricultural and Biological Sciences","cited_by":13,"is_retracted":false,"has_abstract":true,"ca_institutions":"Boehringer Ingelheim (Canada); University of Toronto; McMaster University Medical Centre","funders":"Ablynx; Teva Pharmaceutical Industries; Genentech; AstraZeneca; Amgen; Pfizer; GlaxoSmithKline","keywords":"Medicine; Formoterol; Placebo; Asthma; Crossover study; Anesthesia; Confidence interval; Pulmonary function testing; Bronchodilator; Internal medicine; Budesonide","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006898109,0.001894474,0.005256113,0.0007252638,0.000681562,0.001152473,0.00114712,0.001882136,0.003183173],"category_scores_gemma":[0.00638702,0.0009403438,0.003459297,0.0007232401,0.001572371,0.001479162,0.0005797581,0.002286911,0.0008559357],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000838269,"about_ca_system_score_gemma":0.0009866139,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004842502,"about_ca_topic_score_gemma":0.0004833105,"domain_scores_codex":[0.9951718,0.002925781,0.0004661614,0.0007128455,0.0004032566,0.0003201388],"domain_scores_gemma":[0.9928658,0.002258108,0.001463793,0.001413961,0.0005768763,0.001421457],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.9353331,0.03071579,0.003809638,0.0003603928,0.001243251,0.00005879542,0.0001898533,0.0002614243,0.01035726,0.00002804969,0.0001658829,0.01747656],"study_design_scores_gemma":[0.4709066,0.509577,0.01650026,0.00002029897,0.0007947945,0.00006729662,0.00004244251,0.0002873291,0.001333919,0.00004833728,0.0003890724,0.00003261852],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9964517,0.001325687,0.0004702074,0.00008024416,0.000124184,0.0009089154,0.0002264804,0.00004304363,0.0003694968],"genre_scores_gemma":[0.9952863,0.0006236472,0.001318959,0.0002506103,0.0003662277,0.0009791332,0.0006054069,0.00002403966,0.0005456199],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006898109,"threshold_uncertainty_score":0.03648108,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2813440595265756,"score_gpt":0.4159574604151887,"score_spread":0.1346134008886131,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}